News Focus
News Focus
Followers 55
Posts 1354
Boards Moderated 0
Alias Born 12/31/2013

Re: MI Dendream post# 439312

Friday, 01/28/2022 7:07:28 AM

Friday, January 28, 2022 7:07:28 AM

Post# of 817884
I got one for you (just came up with it). As pseudoprogression became a major issue the company made a strategic decision to move towards OS but were confronted with the crossover issue. So they decided to ditch placebo altogether with the goal of increasing the treatment arm to be compared with external placebos.

The point is, there are too many unknowns and we are just speculating.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News